Streamline Health® Announces 1-For-15 Reverse Stock Split
26 Setembro 2024 - 6:18PM
Streamline Health Solutions, Inc. (“Streamline” or the “Company”)
(NASDAQ: STRM), a leading provider of solutions that enable
healthcare providers to improve financial performance, today
announced that it will proceed with a 1-for-15 reverse stock split
(the “Reverse Stock Split”) of its outstanding shares of Common
Stock (the “Common Stock”) following approval by its Board of
Directors. The 1-for-15 ratio is within the range approved by the
Company’s stockholders at the Special Meeting of Stockholders held
on September 19, 2024.
The Reverse Stock Split is intended to bring the Company into
compliance with the minimum bid price requirement for continued
listing on The Nasdaq Capital Market. The Reverse Stock Split is
expected to become effective at 12:01 a.m., Eastern Daylight Time,
on October 4, 2024 (the “Effective Time”), and the Common Stock is
expected to begin trading on a post-split basis when the market
opens on October 4, 2024, under the new CUSIP number 86323X205. The
Common Stock will continue to be traded on The Nasdaq Capital
Market under the symbol “STRM.”
At the Effective Time, each 15 shares of Common Stock issued and
outstanding will be automatically combined into one share of Common
Stock. No fractional shares will be issued in connection with the
Reverse Stock Split, and, in lieu thereof, the Company will pay
each stockholder of record at the time of effectiveness of the
Reverse Stock Split who otherwise would be entitled to receive
fractional shares (because such stockholder holds a number of
pre-Reverse Stock Split shares not evenly divisible by 15) an
amount in cash equal to the fraction to which the stockholder would
otherwise be entitled multiplied by the closing sales price of the
Common Stock as reported on The Nasdaq Capital Market on the date
on which the Effective Time occurs.
The Reverse Stock Split will also apply to any outstanding
securities or rights convertible into, or exchangeable or
exercisable for, Common Stock and all references to such Common
Stock in agreements, arrangements, documents and plans relating
thereto or any option or right to purchase or acquire shares of
Common Stock shall be deemed to be references to the Common Stock
or options or rights to purchase or acquire shares of Common Stock,
as the case may be, after giving effect to the Reverse Stock Split.
Additionally, all equity awards outstanding immediately prior to
the Reverse Stock Split will be proportionately adjusted.
Computershare Inc. (“Computershare”), the Company’s transfer
agent, is acting as the exchange agent for the Reverse Stock Split.
Stockholders holding their shares electronically in book-entry form
are not required to take any action to receive post-split shares.
Stockholders owning shares through a bank, broker or other nominee
will have their positions adjusted to reflect the Reverse Stock
Split and will receive payment for any fractional shares in
accordance with their respective bank’s, broker’s, or nominee’s
particular processes. Stockholders may direct any questions to
Computershare at (800) 962-4284.
Additional information concerning the Reverse Stock Split can be
found in the Company’s definitive proxy statement on Schedule 14A
filed with the Securities and Exchange Commission on August 19,
2024.
About Streamline Health
Streamline Health Solutions, Inc. (Nasdaq: STRM) enables
healthcare organizations to proactively address revenue leakage and
improve financial performance. We deliver integrated solutions,
technology-enabled services and analytics that drive compliant
revenue leading to improved financial performance across the
enterprise. For more information, visit
www.streamlinehealth.net
Contact
Jacob Goldberger
Vice President, Finance
303.887.9625
jacob.goldberger@streamlinehealth.net
Source: Streamline Health Solutions, Inc.
Streamline Health Soluti... (NASDAQ:STRM)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Streamline Health Soluti... (NASDAQ:STRM)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025